UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number 001-15170
GSK plc
(Translation of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Sir Jonathan Symonds | |||
b) | Position/status | Non-Executive Chair | |||
c) | Initial notification/amendment | Initial notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GSK plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63 | |||
b) | Nature of the transaction | Release of 35,439 notional Ordinary Shares from the GSK Non-Executive Director Share Allocation Arrangements prior to termination of those arrangements, the withholding of 16,656 notional Ordinary Shares for tax and the final release of 18,782 Ordinary Shares representing the balance. These shares will be held by Sir Jonathan Symonds until he retires from the Board | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£14.556 | 18,782 | ||||
d) | Aggregated information | N/A (single transaction) | |||
Aggregated volume Price | |||||
e) | Date of the transaction | 2023-05-04 | |||
f) | Place of the transaction | London Stock Exchange (XLON) |
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr Urs Rohner | |||
b) | Position/status | Independent Non-Executive Director | |||
c) | Initial notification/amendment | Initial notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GSK plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63 | |||
b) | Nature of the transaction | Release of 19,083 notional Ordinary Shares from the GSK Non-Executive Director Share Allocation Arrangements prior to termination of those arrangements, the withholding of 4,446 notional Ordinary Shares for tax and the final release of 14,637 Ordinary Shares representing the balance. These shares will be held by Mr Rohner until he retires from the Board | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£14.556 | 14,637 | ||||
d) | Aggregated information | N/A (single transaction) | |||
Aggregated volume Price | |||||
e) | Date of the transaction | 2023-05-04 | |||
f) | Place of the transaction | London Stock Exchange (XLON) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
GSK plc | |
(Registrant) | |
Date: May 9, 2023 | |
By:/s/ VICTORIA WHYTE -------------------------- | |
Victoria Whyte | |
Authorised Signatory for and on | |
behalf of GSK plc |